Style
GrowthTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | CG Oncology Inc(CGON) | 1,131,500 | $80.4M | 21.94% |
| 2 | Urogen Pharma LTD(URGN) | 1,673,420 | $61.6M | 16.80% |
| 3 | Trevi Therapeutics Inc(TRVI) | 2,144,844 | $40.0M | 10.92% |
| 4 | Candel Therapeutics Inc(CADL) | 3,497,948 | $36.0M | 9.83% |
| 5 | Puma Biotechnology Inc(PBYI) | 4,131,299 | $33.5M | 9.14% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 91.17% | 83.2% | -7.97% |
| Unclassified | 8.83% | 16.8% | +7.97% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Jade Biosceinces Inc(JBIO) |
| 986,760 |
| $21.9M |
| 5.98% |
| 7 | Bicara Therapeutics(BCAX) | 643,381 | $19.1M | 5.21% |
| 8 | Karyopharm Therapeutics Inc(KPTI) | 1,518,113 | $14.8M | 4.05% |
| 9 | Onkure Therapeutics Inc(OKUR) | 2,839,674 | $12.9M | 3.53% |
| 10 | Helus Pharma Inc.(HELP) | 1,540,266 | $10.2M | 2.78% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 29.79% | 44.42% | +14.63% |
| Mid Cap | 47.93% | 21.94% | -25.99% |
| Micro Cap | 13.45% | 16.84% | +3.39% |
| Unclassified | 8.83% | 16.8% | +7.97% |
Quarter-over-quarter position changes